Company Premier Biomedical Inc OTC Bulletin Board
Equities
US74048K1043
Specialty Chemicals
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gabe Vlad
DFI | Director of Finance/CFO | - | - |
William Tynan
AUD | Comptroller/Controller/Auditor | - | - |
General Counsel | - | - | |
Carl Eller
SAM | Sales & Marketing | - | 17-11-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 133,780 | 0 | 0 | 99.00 % |
Stock B | 1 | 1,098,879,075 | 1,087,891,076 ( 99.00 %) | 0 | |
Stock C | 0 | 2,000,000 | 0 | 0 |
Company contact information
Premier Biomedical, Inc.
2409 Sycamore Drive
37921, Knoxville
+724 633 7033
http://www.premierbiomedical.comSales per Business
1st Jan change | Capi. | |
---|---|---|
+22.61% | 69.45B | |
-6.98% | 45.71B | |
+25.26% | 44.6B | |
+31.15% | 27.77B | |
+7.86% | 19.08B | |
-26.60% | 14.77B | |
-10.31% | 15.22B | |
-30.35% | 11.83B | |
-29.96% | 12.05B |
- Stock Market
- Equities
- BIEI Stock
- Stock
- Company Premier Biomedical Inc